Dacarbazine

A potent inhibitor of the kinase activity of ALK2 (IC₅₀ = 13-108 nM) disrupts dorsoventral development in zebrafish affects stem cell development, increasing cardiomyocyte progenitors and promoting neurogenesis inhibits the growth of

An analog of DAG, which inhibits the activation of PKC by DAG.

An analog of DAG, which inhibits the activation of PKC by DAG.

An analog of DAG, which inhibits the activation of PKC by DAG.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

CAS No.: 5802-60-8

O5-tert-butyl O3-methyl 6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxylate.

PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1 . PD-1/PD-L1-IN-23 is an ester proagent of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1 . PD-1/PD-L1-IN-23 displays

PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1 . PD-1/PD-L1-IN-23 is an ester proagent of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1 . PD-1/PD-L1-IN-23 displays

PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1 . PD-1/PD-L1-IN-23 is an ester proagent of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1 . PD-1/PD-L1-IN-23 displays

An inhibitor of DGK (IC₅₀ = 2.8 &microM), increasing DAG-dependent PKC activity blocks vascular contraction induced by U-46619 (Item No.